Abbonarsi

Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making - 14/03/23

Doi : 10.1016/j.ahj.2022.12.007 
Raquel López-Galvez, PhD a, , José Miguel Rivera-Caravaca, RN, PhD a, b, c, , , Vanessa Roldán, MD, PhD d, Esteban Orenes-Piñero, PhD e, María Asunción Esteve-Pastor, MD, PhD a, Cecilia López-García, RN, PhD a, Daniel Saura, MD, PhD a, Josefa González, MD, PhD a, Gregory Y.H. Lip, MD c, f, ⁎⁎, Francisco Marín, MD, PhD a, ⁎⁎
a Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain 
b School of Nursing, University of Murcia, Murcia, Spain 
c Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom 
d Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain 
e Department of Biochemistry and Molecular Biology, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain 
f Department of Clinical Medicine, Aalborg University, Aalborg, Denmark 

$Reprint requests: José Miguel Rivera-Caravaca, RN, PhD, School of Nursing, University of Murcia, Despacho 6.5, Edificio LAIB, Ctra. Buenavista s/n 30120, Murcia, Spain.School of NursingUniversity of MurciaDespacho 6.5, Edificio LAIB, Ctra. Buenavista s/n 30120MurciaSpain

Abstract

The 2020 ESC atrial fibrillation (AF) guidelines suggest the novel 4S-AF scheme for the characterization of AF. Imaging techniques could be helpful for this objective in everyday clinical practice, and information derived from these techniques reflects basic aspects of the pathophysiology of AF, which may facilitate treatment decision-making, and optimal management of AF patients. The aim of this review is to provide an overview of the mechanisms associated with atrial fibrosis and to describe imaging techniques that may help the management of AF patients in clinical practice. Transthoracic echocardiography is the most common procedure given its versatility, safety, and simplicity. Transesophageal echocardiography provides higher resolution exploration, and speckle tracking echocardiography can provide incremental functional and prognostic information over conventional echocardiographic parameters. In addition, LA deformation imaging, including LA strain and strain rate, are related to the extent of fibrosis. On the other hand, multidetector-row computed tomography and cardiac magnetic resonance provide higher resolution data and more accurate assessment of the dimensions, structure, and spatial relationships of the LA. Imaging is central when deciding on catheter ablation or cardioversion, and helps in selecting those patients who will really benefit from these procedures. Moreover, imaging enhances the understanding of the underlying mechanisms of atrial remodeling and might assists in refining the risk of stroke, which help to select the best medical therapies/interventions.

In summary, evaluation of LA enlargement, LA remodeling and fibrosis with imaging techniques adds clinical and prognostic information and should be assessed as a part of routine comprehensive AF evaluation.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : AERP, AF, CMR, CRP, CT, CTDI, ESUS, IL6, LA, LAA, LAEF, LAVi, LGE-CMRI, LV, MDCT, MMPs, PVs, RA, ROS, STE, TDI, TOE, TTE


Mappa


© 2022  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 258

P. 1-16 - Aprile 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial
  • Johanne Silvain, Guillaume Cayla, Emile Ferrari, Grégoire Range, Etienne Puymirat, Nicolas Delarche, Jean-Philippe Collet, Raphaelle Dumaine, Michel Slama, Laurent Payot, Mohamad E. Kasty, Karim Aacha, Eric Vicaut, Gilles Montalescot, ABYSS investigators of the ACTION Study Group,
| Articolo seguente Articolo seguente
  • Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension
  • Giuditta Benincasa, Claudio Napoli, Joseph Loscalzo, Bradley A. Maron

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.